Literature DB >> 19522679

The unique biology of lymphatic edema.

Stanley G Rockson1.   

Abstract

Sadly, the subject of lymphatic vascular insufficiency continues to engender relative neglect by health care professionals, which represents a source of frustration and fear among patients. A re-consideration of the unique, complex biology of lymphatic vascular disorders has the capacity both to reinvigorate interest and facilitate the implementation of the correct, existing treatment interventions for individuals affected by these disease states. While most of this complex lymphatic biology remains somewhat elusive, growing insights into the molecular mechanisms of lymphatic development and repair have been instructive. Present and future considerations in lymphedema diagnosis and management must acknowledge the unique tissue biology of this disorder. Many changes are unique to the lymphatic mechanisms of chronic edema. The profound stimulus to collagen deposition in the integument seems to be unique to chronic lymphatic edema, although this biology remains largely unexplicated. Several lines of evidence also suggest that lymphatic function has a unique and important influence upon adipose biology. Molecular investigation of murine models of human acquired lymphedema are beginning to shed light on these processes. Such focused mechanistic, approaches to the study of lymphedema and other lymphatic diseases are vital, as we attempt to expand our insights into the complex biology of lymphedema and its potential responsiveness to pharmacologic control and molecular intervention, prevention, and reversal.

Entities:  

Mesh:

Year:  2009        PMID: 19522679     DOI: 10.1089/lrb.2009.7202

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  17 in total

1.  Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer.

Authors:  Jie Deng; Sheila H Ridner; Barbara A Murphy; Mary S Dietrich
Journal:  Support Care Cancer       Date:  2011-11-10       Impact factor: 3.603

Review 2.  Rare adipose disorders (RADs) masquerading as obesity.

Authors:  Karen L Herbst
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

3.  The lymphatics and the inflammatory response: lessons learned from human lymphedema.

Authors:  Stanley G Rockson
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

4.  Efficacy of AdipoDren® in Reducing Interleukin-1-Induced Lymphatic Endothelial Hyperpermeability.

Authors:  Valerio Ciccone; Martina Monti; Giulia Antonini; Luisa Mattoli; Michela Burico; Francesca Marini; Anna Maidecchi; Lucia Morbidelli
Journal:  J Vasc Res       Date:  2016-12-07       Impact factor: 1.934

5.  Update on the biology and treatment of lymphedema.

Authors:  Stanley G Rockson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

6.  Unilateral psoriasis in a woman with ipsilateral post-mastectomy lymphedema.

Authors:  Minji Kim; Jae Yoon Jung; Se Young Na; Sun Jae Na; Jong Hee Lee; Soyun Cho
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

7.  Lymph transport in rat mesenteric lymphatics experiencing edemagenic stress.

Authors:  Elaheh Rahbar; Tony Akl; Gerard L Coté; James E Moore; David C Zawieja
Journal:  Microcirculation       Date:  2014-07       Impact factor: 2.628

8.  ROCK and cAMP promote lymphatic endothelial cell barrier integrity and modulate histamine and thrombin-induced barrier dysfunction.

Authors:  Jerome W Breslin
Journal:  Lymphat Res Biol       Date:  2011-03       Impact factor: 2.589

9.  Lymphaticosclerosis: a new way of thinking about lymphatic vessel obstruction.

Authors:  A Trujillo; J W Breslin
Journal:  Br J Dermatol       Date:  2015-05       Impact factor: 9.302

Review 10.  Development of the endothelium: an emphasis on heterogeneity.

Authors:  Laura A Dyer; Cam Patterson
Journal:  Semin Thromb Hemost       Date:  2010-05-20       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.